| P2093 | author name string | A John Barrett | |
| | Kristina Broliden | |
| | Agneta Wikman | |
| | Katarina Le Blanc | |
| | Mikael Sundin | |
| | Claes Orvell | |
| | Anna Lindblom | |
| | Berit Sundberg | |
| | Emma Watz | |
| P2860 | cites work | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 |
| | Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 |
| | Marrow stromal cells as stem cells for nonhematopoietic tissues | Q29618770 |
| | Parvovirus B19 transmitted by bone marrow | Q33335447 |
| | Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation | Q33338991 |
| | Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro | Q33394816 |
| | Parvovirus-like particles in human sera | Q34214388 |
| | Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). | Q34338090 |
| | Clinical aspects of CMV infection after stem cell transplantation | Q35789339 |
| | Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication | Q36483931 |
| | Clinical aspects of parvovirus B19 infection | Q36589340 |
| | Risk assessment in haematopoietic stem cell transplantation: viral status | Q36797756 |
| | Integrin expression in stem cells from bone marrow and adipose tissue during chondrogenic differentiation. | Q40121968 |
| | Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection | Q40389867 |
| | Multiple Glycosphingolipids Determine the Tissue Tropism of Parvovirus B19 | Q41277281 |
| | DNA replication of parvovirus B 19 in a human erythroid leukemia cell line (JK-1) in vitro | Q41584056 |
| | Human immunodeficiency virus infection of human bone marrow stromal fibroblasts | Q41728148 |
| | Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry | Q44542238 |
| | Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction | Q45408517 |
| | The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation. | Q45413771 |
| | Erythrocyte P antigen: cellular receptor for B19 parvovirus | Q45873217 |
| | Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. | Q52196589 |
| | Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual. | Q53628192 |
| | Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues | Q53745526 |
| | Slow clearance of human parvovirus B19 viremia following acute infection | Q59315598 |
| | Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease | Q63197317 |
| | Characterization of cells with osteogenic potential from human marrow | Q68117980 |
| | B19 parvovirus replicates in erythroid leukemic cells in vitro | Q69680765 |
| | Induction of DNA synthesis in human lymphocytes: interaction between non-specific mitogens and antigens | Q71582131 |
| | A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA | Q73559230 |
| | Evidence for persistence of human parvovirus B19 DNA in bone marrow | Q73870588 |
| | HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells | Q79149793 |
| | Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells | Q80413361 |
| | Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products | Q81444776 |
| P433 | issue | 10 | |
| P304 | page(s) | 1172-1179 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation | |
| P478 | volume | 14 | |